Skip to main content

Advertisement

Log in

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients

  • Pharmacogenetics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study is to examine the association of HLA-B*1502 allele with CBZ-induced SJS/TEN in the mainland Han Chinese population.

Methods

HLA-B*1502 genotyping with sequence-specific primer polymerase chain reaction (PCR-SSP) and PCR-sequencing based typing (PCR-SBT) was performed on 17 CBZ-induced SJS/TEN patients, 21 CBZ-tolerant controls, and 185 healthy controls recruited during 2008–2010.

Results

HLA-B*1502 allele was present in 94.1% (16/17) of CBZ-SJS/TEN patients, 9.5% (2/21) of CBZ-tolerant patients, and 9.2% (17/185) of healthy controls. The risk of CBZ-induced SJS/TEN was significantly higher (P < 0.01) in the patients with HLA-B*1502. One CBZ-induced SJS patient tested negative for HLA-B*1502, and the test result showed HLA-B*3503/B*4601.

Conclusions

We found a strong association between HLA-B*1502 and CBZ-induced SJS/TEN in the Han Chinese population from central and northern China. Combined with previous studies of the southern Han Chinese subpopulation, our results suggest that HLA-B*1502 is strongly associated with CBZ-induced SJS/TEN in the whole Han Chinese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R (1999) Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet 353(9171):2190–2194

    Article  PubMed  CAS  Google Scholar 

  2. Ferrell PB Jr, McLeod HL (2008) Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics 9(10):1543–1546

    Article  PubMed  CAS  Google Scholar 

  3. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982):486

    Article  PubMed  CAS  Google Scholar 

  4. Hung SI, Chung WH, Jee SH et al (2006) Genetic susceptibility to carbamazepine induced cutaneous adverse drug reactions. Pharmacogenet Genomics 16:297–306

    Article  PubMed  CAS  Google Scholar 

  5. Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH (2007) Association between HLA-B*1502 allele and antiepileptic drug induced cutaneous reactions in Han Chinese. Epilepsia 48(5):1015–1018, erratum in: Epilepsia 49(5): 941 (2008)

    Article  PubMed  CAS  Google Scholar 

  6. Locharernkul C, Loplumlert J, Limotai C et al (2008) Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49(12):2087–2091

    Article  PubMed  Google Scholar 

  7. Lonjou C, Borot N, Sekula P et al (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99–107

    Article  PubMed  CAS  Google Scholar 

  8. Kaniwa N, Saito Y, Aihara M et al (2008) HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9(11):1617–1622

    Article  PubMed  CAS  Google Scholar 

  9. Xu S, Yin X, Li S et al (2009) Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 85(6):762–774

    Article  PubMed  CAS  Google Scholar 

  10. Roujeau JC (1994) The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 102:28S–30S

    Article  PubMed  CAS  Google Scholar 

  11. Mockenhaupt M (2009) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges 7(2):142–160

    PubMed  Google Scholar 

  12. Yu N, Ohashi M, Alosco S, Salazar M, Cao K, Fernandez Vina M, Yunis EJ (1998) Typing of HlA-B*15 alleles using sequencespecific primers. Tissue Antigens 52(3):260–269

    Article  PubMed  CAS  Google Scholar 

  13. Barnardo MC, Welsh KI, Vilches C, Maitland K, Bunce M (1998) Allele specific HLA-B*15 typing by PCR-SSP and its application to four distinct ethnic populations. Tissue Antigens 51:293–300

    Article  PubMed  CAS  Google Scholar 

  14. Marsh SGE (2009) HLA-B nucleotide sequence alignments sequences aligned, 17 Apr 2009. HLA nomenclature. http://hla.alleles.org/data/txt/b_nuc.txt

  15. Yuan F, Sun YY, Liang F, Jin L, Luo Y, Tan LX, Xi YZ (2008) Polymorphism of classical HLA-I genes in Chinese Han population from different areas. Chin Med Biotechnol 3(5):343–348

    Google Scholar 

  16. Middleton D, Hawkins BR, Williams F, Meenagh A, Moscoso J, Zamora J, Arnaiz Villena A (2004) HLA class I allele distribution of a Hong Kong Chinese population based on high-resolution PCR-SSOP typing. Tissue Antigens 63(6):555–561

    Article  PubMed  CAS  Google Scholar 

  17. Saito S, Ota S, Yamada E, Inoko H, Ota M (2000) Allele frequencies and haplotypic association defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56(6):522–529

    Article  PubMed  CAS  Google Scholar 

  18. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford University Press, Oxford, pp 1065–1220

    Google Scholar 

  19. Tassaneeyakul W, Tiamkao S, Jantararoungtong T et al (2010) Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 51(5):926–930

    PubMed  Google Scholar 

  20. Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK (2009) Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 75(6):579–582

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported by a grant from the National Natural Science Foundation of China (no. 30973597), the Key Funds for Major State Basic Research Program of Suzhou (SYS201001), and Chinese National High Technology Research and Development Program 863 (2008AA02Z436). We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. None of the authors has any conflict of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Li-Yan Miao.

Additional information

Yan Zhang and Jin Wang contributed equally to this work.

Electronic supplementary materials

Below is the link to the electronic supplementary material.

ESM 1

(DOC 78 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, Y., Wang, J., Zhao, LM. et al. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients. Eur J Clin Pharmacol 67, 885–887 (2011). https://doi.org/10.1007/s00228-011-1009-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-011-1009-4

Keywords

Navigation